Granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory lung diseases: pathogenic contributor and therapeutic target

Authors

  • Muhammad Afzal Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia https://orcid.org/0000-0003-2570-3223
  • Sami I. Alzarea Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf 72341, Saudi Arabia https://orcid.org/0000-0003-4007-4023
  • Imran Kazmi Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia https://orcid.org/0000-0003-1881-5219
  • Abida Khan Center For Health Research, Northern Border University, Arar 73213, Saudi Arabia https://orcid.org/0000-0001-6186-461X
  • Surya Nath Pandey Department of Pharmacology, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad 244001 Uttar Pradesh, India https://orcid.org/0000-0003-2277-8174
  • Arcot Rekha Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune 411018, Maharashtra, India https://orcid.org/0000-0001-7036-0712
  • Rakhi Mishra Noida Institute of Engineering and Technology (Pharmacy Institute), 19 Knowledge Park 2, Greater Noida, India https://orcid.org/0000-0002-9292-3448
  • Deepika Raina Faculty of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand, India; Department of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, 248002, Uttarakhand, India https://orcid.org/0000-0003-1859-0646
  • Jyoti Maithani Kalra School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Dehradun, 248001, Uttarakhand, India https://orcid.org/0000-0002-4960-6551
  • Kapil Kalra Alpine College of Management and Technology, Dehradun, 248007, Uttarakhand, India https://orcid.org/0000-0001-7739-7614
  • Gaurav Gupta Centre for Research Impact and Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates https://orcid.org/0000-0001-7941-0229
  • Md Sadique Hussain Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India. E-mail: sadiquehussain007@gmail.com https://orcid.org/0000-0002-3554-1750

DOI:

https://doi.org/10.17179/excli2026-9692

Keywords:

Granulocyte-macrophage colony-stimulating factor, asthma, COPD, lung cancer, inflammation

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an integral pathogenic factor in inflammatory lung pathologies including asthma, COPD, and lung cancer. As a pro-inflammatory cytokine, GM-CSF triggers the division and stimulation of granulocytes and macrophages, exacerbating the inflammatory response and promoting lung tissue damage. GM-CSF is an essential factor in promoting the production of the corresponding cytokines, levelling the effect of local activity by stimulating the infiltration of immune cells and maintaining chronic inflammation. Therefore, its neutralization in many ways leads to the cessation of the progression and exacerbation of inflammation in the lungs of patients with corresponding pathologies. Inhibitory therapy associated with GM-CSF reduces the number of immune cells and activates them at the inflammatory focus. The use of neutralizing antibodies to treat an acute inflammatory process is promising because they relatively quickly neutralize the effect of pathogenic GM-CSF. However, the immunocyte response can also be inhibited at the level of formation. Therapy with GM-CSF inhibitors can significantly reduce acute inflammation but can lead to adverse changes in the innate immunity of the patient. This review highlights GM-CSF's dual function of GM-CSF as a pathogenic contributor and possible treatment targets.

Downloads

Published

2026-10-22

How to Cite

Afzal, M., Alzarea, S. I., Kazmi, I., Khan, A., Pandey, S. N., Rekha, A., … Hussain, M. S. (2026). Granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory lung diseases: pathogenic contributor and therapeutic target. EXCLI Journal, 25, 1588–1633. https://doi.org/10.17179/excli2026-9692

Issue

Section

Review articles

Categories

Most read articles by the same author(s)

1 2 3 4 > >>